Product Information
GLATIRAMER 40 MG/ML SYRINGE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $86.0952 per ML under NDC 47335099102. Its NADAC has been published 51 times since Oct 15, 2025.
FDA first approved this application on Sep 25, 2024. Its Orange Book therapeutic-equivalence code is AP.
Strength
40 mg/mL
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335099102
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
GLATIRAMER ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA206873FDA Approved
9/25/2024
TE Code
AP
On Market Since
8/15/2025
Price Statistics
The NADAC for GLATIRAMER 40 MG/ML SYRINGE has been published 51 times since Oct 15, 2025, and over the history we have for it it has declined 19.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $86.0952 per ML |
|---|---|
| All-time high | $106.9416 (Oct 15, 2025) |
| All-time low | $86.0952 (Sep 23, 2026) |
| 52-week high | $106.9416 |
| 52-week low | $86.0952 |
| Median price | $101.2365 |
| Average price | $99.0345 |
| Largest weekly change | -5.5% (Sep 23, 2026) |
| Weeks tracked | 51 |
| Tracking since | Oct 15, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glatiramer Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLATIRAMER 40 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for GLATIRAMER 40 MG/ML SYRINGE, manufactured by Sun Pharmaceutical Industries Inc., is $86.0952 per ML (NDC 47335099102), effective Sep 30, 2026.
How has the price of GLATIRAMER 40 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for GLATIRAMER 40 MG/ML SYRINGE has declined 19.5%. It has been tracked across 51 weekly CMS publications since Oct 15, 2025.
What are the highest and lowest recorded NADAC prices for GLATIRAMER 40 MG/ML SYRINGE?
Since Oct 15, 2025, the NADAC for GLATIRAMER 40 MG/ML SYRINGE has ranged from a low of $86.0952 (Sep 23, 2026) to a high of $106.9416 (Oct 15, 2025), with a median of $101.2365 per ML.
Are there cheaper alternatives to GLATIRAMER 40 MG/ML SYRINGE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GLATIRAMER 40 MG/ML SYRINGE in a comparable dosage form, but none are currently priced below it.
Who manufactures GLATIRAMER 40 MG/ML SYRINGE?
GLATIRAMER 40 MG/ML SYRINGE (NDC 47335099102) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.